[1] Schillaci O, Buscombe JR.  Breast scintigraphy today: indications and limitations[J]. Eur J Nucl Med Mol Imaging, 2004, 31 Suppl 1: S35-45.   doi: 10.1007/s00259-004-1525-x
[2]

Yu X, Hu G, Zhang Z, et al. Retrospective and comparative analysis of 99mTc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women[J/OL]. BMC Cancer, 2016, 16: 450[2018-05-05]. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2537-1. DOI: 10.1186/s12885-016-2537-1.
[3] Cho MJ, Yang JH, Yu YB, et al.  Validity of breast-specific gamma imaging for Breast Imaging Reporting and Data System 4 lesions on mammography and/or ultrasound[J]. Ann Surg Treat Res, 2016, 90(4): 194-200.   doi: 10.4174/astr.2016.90.4.194
[4] Goldsmith SJ, Parsons W, Guiberteau MJ, et al.  SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0[J]. J Nucl Med Technol, 2010, 38(4): 219-224.   doi: 10.2967/jnmt.110.082271
[5] Brem RF, Floerke AC, Rapelyea JA, et al.  Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer[J]. Radiology, 2008, 247(3): 651-657.   doi: 10.1148/radiol.2473061678
[6] Meissnitzer T, Seymer A, Keinrath P, et al.  Added value of semi-quantitative breast-specific gamma imaging in the work-up of suspicious breast lesions compared to mammography, ultrasound and 3-T MRI[J]. Br J Radiol, 2015, 88(1051): 20150147-.   doi: 10.1259/bjr.20150147
[7] Kuhn KJ, Rapelyea JA, Torrente J, et al.  Comparative Diagnostic Utility of Low-Dose Breast-Specific Gamma Imaging to Current Clinical Standard[J]. Breast J, 2016, 22(2): 180-188.   doi: 10.1111/tbj.12550
[8] Tan H, Jiang L, Gu Y, et al.  Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer[J]. Ann Nucl Med, 2014, 28(1): 17-24.   doi: 10.1007/s12149-013-0776-7
[9] Park JS, Lee AY, Jung KP, et al.  Diagnostic Performance of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer: Usefulness of Dual-Phase Imaging with 99mTc-sestamibi[J]. Nucl Med Mol Imaging, 2013, 47(1): 18-26.   doi: 10.1007/s13139-012-0176-2
[10] Rechtman LR, Lenihan MJ, Lieberman JH, et al.  Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts[J]. AJR Am J Roentgenol, 2014, 202(2): 293-298.   doi: 10.2214/AJR.13.11585
[11] Del VS, Salvatore M.  99mTc-MIBI in the evaluation of breast cancer biology[J]. Eur J Nucl Med Mol Imaging, 2004, 31 Suppl 1: S88-96.   doi: 10.1007/s00259-004-1530-0
[12] 杜勇, 任长征, 龙艳.  乳腺肿块99mTc-MIBI显像规律与其组织病理学关系的初步探讨[J]. 中华核医学杂志, 1997, 17(1): 43-45.   doi: 10.1007/BF02951625
Du Y, Ren CZ, Long Y.  The relationship between the 99mTc-MIBI imaging characteristics and the histopathologic features of breast tumors[J]. Chin J Nucl Med, 1997, 17(1): 43-45.   doi: 10.1007/BF02951625
[13] Tadwalkar RV, Rapelyea JA, Torrente J, et al.  Breast-specific gamma imaging as an adjunct modality for the diagnosis of invasive breast cancer with correlation to tumour size and grade[J]. Br J Radiol, 2012, 85(1014): e212-216.   doi: 10.1259/bjr/34392802
[14] Moscoso A, Ruibal Á, Domínguez-Prado I, et al.  Texture analysis of high-resolution dedicated breast 18F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer[J]. Eur J Nucl Med Mol Imaging, 2018, 45(2): 196-206.   doi: 10.1007/s00259-017-3830-1
[15] Jones EA, Phan TD, Blanchard DA, et al.  Breast-specific gamma-imaging: molecular imaging of the breast using 99mTc-sestamibi and a small-field-of-view gamma-camera[J]. J Nucl Med Technol, 2009, 37(4): 201-205.   doi: 10.2967/jnmt.109.063537